AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2020-01 · 183 (1) · 51-60
DOI: 10.1002/ajmg.b.32760 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, online erschienen am 27.08.2019. Verfasst von Robert Philibert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Iowa, Iowa City, Iowa. Hauptthemen laut MEDLINE: DNA Methylation. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: NCI NIH HHS, NIAAA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Many existing DNA repositories do not have robust characterizations of smoking, while for many currently ongoing studies, the advent of vaping has rendered traditional cotinine‐based methods of determining smoking status unreliable. Previously, we have shown that methylation status at cg05575921 in whole blood DNA can reliably predict cigarette consumption. However, whether methylation status in saliva can be used similarly has yet to be established. Herein, we use DNA from 418 biochemically confirmed smokers or nonsmokers to compare and contrast the utility of cg05575921 in classifying and quantifying cigarette smoking. Using whole blood DNA, a model incorporating age, gender, and methylation status had a receiver operating characteristic (ROC) area under the curve (AUC) for predicting smoking status of 0.995 with a nonlinear demethylation response to smoking. Using saliva DNA, the ROC AUC for predicting smoking was 0.971 with the plot of the relationship of DNA methylation to daily cigarette consumption being very similar to that seen for whole blood DNA. The addition of information from another methylation marker designed to correct for cellular heterogeneity improved the AUC for saliva DNA to 0.981. Finally, in 31 subjects who reported quitting smoking 10 or more years previously, cg05575921 methylation was nonsignificantly different from controls. We conclude that DNA methylation status at cg05575921 in DNA from whole blood or saliva predicts smoking status and daily cigarette consumption. We suggest these epigenetic assessments for objectively ascertaining smoking status will find utility in research, clinical, and civil applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Iowa, Iowa City, Iowa.
- Behavioral Diagnostics LLC, Coralville, Iowa.
- Cardio Diagnostics LLC, Coralville, Iowa.
- Center for Family Studies, University of Georgia, Athens, Georgia.
- Department of Biostatistics, University of Iowa, Iowa City, Iowa.
ORCID-Profile: Robert Philibert, Steven R H Beach
Förderung
- NCI NIH HHS
- NIAAA NIH HHS
- National Institutes of Health
Zitieren
APA
Philibert, R., Dogan, M., Beach, S. R. H., Mills, J. A., & Long, J. D. (2020). AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 183(1), 51-60. https://doi.org/10.1002/ajmg.b.32760
Vancouver
Philibert R, Dogan M, Beach SRH, Mills JA, Long JD. AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2020;183(1):51-60. doi:10.1002/ajmg.b.32760
BibTeX
@article{Philibert2020,
author = {Philibert, Robert and Dogan, Meeshanthini and Beach, Steven R H and Mills, James A and Long, Jeffrey D},
title = {AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA},
journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
year = {2020},
volume = {183},
number = {1},
pages = {51--60},
doi = {10.1002/ajmg.b.32760}
}
EUVIMED